Literature DB >> 21195308

Graft versus leukemia reactivity after allogeneic stem cell transplantation.

J H Frederik Falkenburg1, Edus H Warren.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21195308     DOI： 10.1016/j.bbmt.2010.11.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  15 in total

1.  Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.

Authors:  Cornelis A M van Bergen; Simone A P van Luxemburg-Heijs; Liesbeth C de Wreede; Matthijs Eefting; Peter A von dem Borne; Peter van Balen; Mirjam H M Heemskerk; Arend Mulder; Fransiscus H J Claas; Marcelo A Navarrete; Wilhelmina M Honders; Caroline E Rutten; Hendrik Veelken; Inge Jedema; Constantijn J M Halkes; Marieke Griffioen; J H Frederik Falkenburg
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

2.  HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.

Authors:  W Herr; Y Eichinger; J Beshay; A Bloetz; S Vatter; C Mirbeth; E Distler; U F Hartwig; S Thomas
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

Review 3.  Mesenchymal stromal cells: a new tool against graft-versus-host disease?

Authors:  Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

4.  Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques.

Authors:  Jason T Weinfurter; Saritha S D'Souza; Lea M Matschke; Sarah Bennett; Laurel E Kelnhofer-Millevolte; Kran Suknuntha; Akhilesh Kumar; Jennifer Coonen; Christian M Capitini; Peiman Hematti; Thaddeus G Golos; Igor I Slukvin; Matthew R Reynolds
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

Review 5.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

6.  Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

Authors:  Cornelis A M van Bergen; Elisabeth M E Verdegaal; M Wilhelmina Honders; Conny Hoogstraten; A Q M Jeanne Steijn-van Tol; Linda de Quartel; Joan de Jong; Maaike Meyering; J H Frederik Falkenburg; Marieke Griffioen; Susanne Osanto
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 7.  Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets.

Authors:  Marieke Griffioen; Cornelis A M van Bergen; J H Frederik Falkenburg
Journal:  Front Immunol       Date:  2016-03-15       Impact factor: 7.561

8.  Rapid Multiplex Genotyping of 20 HLA-A*02:01 Restricted Minor Histocompatibility Antigens.

Authors:  Dmitrii S Romaniuk; Anna M Postovskaya; Alexandra A Khmelevskaya; Dmitry B Malko; Grigory A Efimov
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

9.  The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants.

Authors:  Dyantha I van der Lee; Margot J Pont; J H Frederik Falkenburg; Marieke Griffioen
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

10.  In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project.

Authors:  Nadia A Bykova; Dmitry B Malko; Grigory A Efimov
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.